88 related articles for article (PubMed ID: 25200216)
1. Does bosentan protect diabetic brain alterations in rats? The role of endothelin-1 in the diabetic brain.
Demir R; Cadirci E; Akpinar E; Cayir Y; Atmaca HT; Un H; Kunak CS; Yayla M; Bayraktutan Z; Demir I
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):236-43. PubMed ID: 25200216
[TBL] [Abstract][Full Text] [Related]
2. Role of endothelin receptors and relationship with nitric oxide synthase in impaired erectile response in diabetic rats.
Alkan E; Ugan RA; Basar MM; Halici Z; Karakus E; Balbay MD; Un H
Andrologia; 2017 Mar; 49(2):. PubMed ID: 27145076
[TBL] [Abstract][Full Text] [Related]
3. Endothelin receptor inhibition with bosentan delays onset of liver injury in streptozotocin-induced diabetic condition.
Demirci E; Ferah I; Gundogdu C; Ozkanlar S; Baygutalp NK; Bayir Y; Calik M; Ayaz G
Drug Res (Stuttg); 2015 May; 65(5):272-80. PubMed ID: 24918345
[TBL] [Abstract][Full Text] [Related]
4. Bosentan ameliorates the expression of fibrotic related growth factors and collagen-1 in diabetic mice.
Yang B; Li M; Shi ZG; Feng QZ
Anadolu Kardiyol Derg; 2012 Dec; 12(8):621-7. PubMed ID: 22968296
[TBL] [Abstract][Full Text] [Related]
5. Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats.
Jesmin S; Zaedi S; Maeda S; Yamaguchi I; Goto K; Miyauchi T
Exp Biol Med (Maywood); 2006 Jun; 231(6):925-31. PubMed ID: 16741025
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of bosentan, a dual ETA and ETB endothelin receptor antagonist, in experimental diabetes induced vascular endothelial dysfunction and associated dementia in rats.
Singh G; Sharma B; Jaggi AS; Singh N
Pharmacol Biochem Behav; 2014 Sep; 124():27-35. PubMed ID: 24836182
[TBL] [Abstract][Full Text] [Related]
7. Chronic bosentan treatment improves renal artery vascular function in diabetes.
Arikawa E; Verma S; Dumont AS; McNeill JH
J Hypertens; 2001 Apr; 19(4):803-12. PubMed ID: 11330884
[TBL] [Abstract][Full Text] [Related]
8. The lung endothelin system: a potent therapeutic target with bosentan for the amelioration of lung alterations in a rat model of diabetes mellitus.
Cayir A; Ugan RA; Albayrak A; Kose D; Akpinar E; Cayir Y; Atmaca HT; Bayraktutan Z; Kara M
J Endocrinol Invest; 2015 Sep; 38(9):987-98. PubMed ID: 25847324
[TBL] [Abstract][Full Text] [Related]
9. Long-term endothelin receptor blockade improves cardiovascular function in diabetes.
Verma S; Arikawa E; McNeill JH
Am J Hypertens; 2001 Jul; 14(7 Pt 1):679-87. PubMed ID: 11465653
[TBL] [Abstract][Full Text] [Related]
10. Effects of endothelin receptor antagonism with bosentan on peripheral nerve function in experimental diabetes.
Stevens EJ; Tomlinson DR
Br J Pharmacol; 1995 May; 115(2):373-9. PubMed ID: 7670740
[TBL] [Abstract][Full Text] [Related]
11. Levels of endothelin-1 in embryos from control and neonatal streptozotocin-induced diabetic rats, and their relationship with nitric oxide generation.
Sinner D; Jawerbaum A; Pustovrh C; White V; Capobianco E; Gonzalez E
Reprod Fertil Dev; 2002; 14(1-2):23-8. PubMed ID: 12051519
[TBL] [Abstract][Full Text] [Related]
12. Exaggerated coronary reactivity to endothelin-1 in diabetes: reversal with bosentan.
Verma S; Arikawa E; Lee S; Dumont AS; Yao L; McNeill JH
Can J Physiol Pharmacol; 2002 Oct; 80(10):980-6. PubMed ID: 12450064
[TBL] [Abstract][Full Text] [Related]
13. The effect of alpha-lipoic acid on NOS dispersion in the lung of streptozotocin-induced diabetic rats.
Hürdağ C; Uyaner I; Gürel E; Utkusavas A; Atukeren P; Demirci C
J Diabetes Complications; 2008; 22(1):56-61. PubMed ID: 18191078
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of Et-1 receptor antagonist bosentan on paracetamol induced acute liver toxicity in rats.
Yayla M; Halici Z; Unal B; Bayir Y; Akpinar E; Gocer F
Eur J Pharmacol; 2014 Mar; 726():87-95. PubMed ID: 24462570
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with taurine ameliorates diabetes-induced dysfunction of nitric oxide-mediated neurogenic and endothelium-dependent corpus cavernosum relaxation in rats.
Dalaklioglu S; Kuscu N; Celik-Ozenci C; Bayram Z; Nacitarhan C; Ozdem SS
Fundam Clin Pharmacol; 2014 Aug; 28(4):394-404. PubMed ID: 23848484
[TBL] [Abstract][Full Text] [Related]
16. Dual endothelin receptor antagonism with bosentan reverses established vascular remodeling and dysfunctional angiogenesis in diabetic rats: relevance to glycemic control.
Abdelsaid M; Kaczmarek J; Coucha M; Ergul A
Life Sci; 2014 Nov; 118(2):268-73. PubMed ID: 24447630
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin reduces proteinuria in streptozotocin-induced diabetic Wistar rats.
Nakamaki S; Satoh H; Kudoh A; Hayashi Y; Hirai H; Watanabe T
Exp Biol Med (Maywood); 2011 May; 236(5):614-20. PubMed ID: 21521713
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective endothelin (ET)-A receptor antagonist versus dual ET-A/B receptor antagonist on hearts of streptozotocin-treated diabetic rats.
Miyauchi Y; Jesmin S; Sakai S; Kamiyama J; Shimojo N; Rahman A; Islam M; Zaedi S; Maeda S; Maruyama H; Mizutani T; Homma S; Aonuma K; Miyauchi T
Life Sci; 2014 Aug; 111(1-2):6-11. PubMed ID: 24953608
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of nanostructures of hydrated C(60) fullerene on reproductive function in streptozotocin-diabetic male rats.
Bal R; Türk G; Tuzcu M; Yilmaz O; Ozercan I; Kuloglu T; Gür S; Nedzvetsky VS; Tykhomyrov AA; Andrievsky GV; Baydas G; Naziroglu M
Toxicology; 2011 Apr; 282(3):69-81. PubMed ID: 21163323
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-1-mediated alteration of metallothionein and trace metals in the liver and kidneys of chronically diabetic rats.
Cai L; Chen S; Evans T; Cherian MG; Chakrabarti S
Int J Exp Diabetes Res; 2002; 3(3):193-8. PubMed ID: 12458661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
